Mulmit

CG Oncology, Inc.CG Oncology, Inc.

CGON Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-314,040,000-190,774,000-161,000,000-2.08
2024-12-311,139,000-114,666,000-88,040,000-1.41
2023-12-31204,000-55,449,000-48,607,000-15.65

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-14POST LEONARD E1,000
2026-08-14POST LEONARD E1,000
2026-08-14POST LEONARD E1,000
2026-07-15POST LEONARD E1,000
2026-07-15POST LEONARD E1,000
2026-07-15POST LEONARD E1,000
2026-07-10Mulay James24,165
2026-07-10Mulay James24,165
2026-07-10Mulay James24,165
2026-06-25Liu Brian Guan-Chyun371,085
2026-06-24POST LEONARD E5,000
2026-06-24POST LEONARD E5,000

8-K events

FiledItems
2026-08-06Results of operations · Other events · Financial statements and exhibits
2026-06-08Submission of matters to a vote
2026-05-26Officer or director change
2026-05-08Results of operations · Financial statements and exhibits
2026-04-13Officer or director change · Financial statements and exhibits
2026-02-27Results of operations · Financial statements and exhibits
2026-01-13Other events · Financial statements and exhibits
2026-01-09Regulation FD disclosure · Other events · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.